Stay updated with breaking news from Small Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Small Pharma Inc. (CVE:DMT – Get Free Report)’s share price fell 6.3% on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 1,890,765 shares traded hands during trading, an increase of 538% from the average session volume of 296,159 shares. The stock had previously closed at C$0.16. Small Pharma Trading […]
Clinical-stage psychedelics biotech Cybin Inc. (NYSE: CYBN) released its financial results for second quarter ended September 30, 2023.
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted Psychedelics companies Cybin Inc. (NYSE:CYBN) and Small Pharma I...
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.